PHARM Block 1 Flashcards
(272 cards)
1
Q
Pharmacology
A
The science of drug action on biological systems
Pharmaco = medicine / drug
logy = study
2
Q
Pharmacy
A
clinical practice devoted to the formulation, proper and safe distribution and use of drug
3
Q
Pharmaceutical Drug
A
chemical substance for medical diagnosis, treatment, or prevention of disease
4
Q
Discuss the first recordings of drug action
A
China: Chen Nog in 200 B.C was a divine farmer and Chinese herbal medicine
Egypt: The book of Thoth is the world’s oldest preserved medical and pharmacological record
5
Q
What did Galen introduce
A
The study of anatomy and described the actions of agonists and antagonist
6
Q
During the Islamic Golden Age, scientists developed an understanding of
A
drug quantities and formulations
7
Q
Who is Swiss-German physician-scholar Paracelsus
A
The father of toxicology, the dose makes the poison
8
Q
Who is William Withering and what is his connection to Tucson
A
An English botanist that discovered digitalis treat congestive heart failure
digitalis (fox glove) is native to Tucson
but if you use the Nerium oleander then it is poisonous to humans
9
Q
What did the Lewis and Clark expedition discover
A
willow bark tea to treat fever and pains because salicilin is metabolized to aspirin
10
Q
Who is Friedrich Serturner
A
Isolated alkaloid from opium and over dosed
named morphine from the Greek god of dreams, Morpheus
11
Q
Who is Friedrich Wohler
A
founded synthetic organic chemistry
12
Q
Who is Hippocrates
A
The Father of Western Medicine and began the separation of medicine from religion and superstition
13
Q
Who is Claude Bernard
A
Founded the concept of homeostasis
14
Q
Pharmacodynamics
A
The mechanism of drug action
15
Q
How do drugs act on receptors
A
usually proteins which result in a change in the system
16
Q
What are effectors
A
molecules that translate the receptor - drug interaction into a change in cellular activity
17
Q
Discuss the misleading nature of the Lock and Key model of molecular pharmacology
A
it is not simply turned on or turn off
Instead, think of receptors as fluctuating between favored and disfavored energy states constantly
18
Q
R*
A
disfavored, active, high-energy state
19
Q
R
A
favored low - energy state
20
Q
What do agonists do
A
lower the free energy of the activated state and this will make it more favorable than the baseline state.
*cycling between states still continues
21
Q
Binding of a ligand can
A
cause an induce fit which is a conformation shift of the receptor that can cause effector signaling
22
Q
Are receptors ever completely on or completely off
A
No, even some imperfect agonists can still stimulate the receptor given enough concentration
23
Q
Discuss the Saturation Radioligand Binding as a key method for measuring the binding of a drug to a receptor
A
-Membrane preparation of tissue or cells with target
-Increasing concentrations of radiolabeled drug
-Non‐specific binding component
-Saturating concentrations of cold selective ligand
-Reaction proceeds to equilibrium
-you have your ligand (drug) and it is radiolabled and its going to bind and saturate it (high affinity low capacity systems) and you can use it to measure how well the drug binds to its binding site
24
Q
Competition Radioligand Binding
A
A known amount of radiolabeled established drug is competed off of a receptor by a non - radiolabeled drug with unknown affinity
-two drugs competing for a binding site and they compete by affinity and concentration
- the less it takes for the drug to compete away to higher the affinity
*Allosteric sites are a problem
25
Bmax
Total number of binding sites
26
Kd
Binding constant (affinity) of the drug
27
Why do you not want to use Saturation Binding?
Because you do not want to radiolabel a bunch of drugs, therefore you would use Competition Radioligand Binding
28
IC50
Concentration at 50% inhibition
29
The data obtained is the IC50. IS this the same as the drug affinity?
No, this is not the drug affinity because if you double the radio labeled drug then you have twice as much drug to compete away .
IC50 is depended upon the concentrations of the two drugs
30
Ki
Binding Constant (affinity) of our experimental, unlabeled drug
31
Assumptions of the experiment
-Bound concentration is negligible compared to free
-No binding cooperativity
-At equilibrium
-Binding is reversible and follows Law of Mass Action
32
Most drug binding to receptors involve
non - covalent interaction with key amino acids
33
Efficacy
E max
34
Potency
EC50, ED50
35
Can a partial agonist be more than a full agonist
A full agonist reaches the maximal response capability of the system, and a partial agonist does not (even at full receptor occupancy)
36
How are affinity and potency different
Affinity defines the strength of attraction between the drug and its receptor. A high affinity is generally associated with a lower dose requirement (compared to low affinity for the same receptor). Potency describes the relationship between the drug dose and the magnitude of the effect
37
Can antagonists be competitive and non competitive
Yes, competitive and reversible binding and non competitive is irreversible which will reduce the total amount of receptors available to bind agonist
38
Antagonists
bind to the target but do not cause a conformation shift , therefore baseline activity is still the same
*cause agonist to not be able to bind so you can only see the effects of an antagonist when an agonist is present
39
Agonists
a substance which initiates a physiological response when combined with a receptor
40
Inverse agonists
bind to the receptor, but shift the energy landscape baseline (R) is lower and / or the active state (R*) is higher so the receptor spends even less time in the active state than before
41
Drug selectivity
Selectivity deals with how well your drug binds to your preferred target vs other targets.
42
Side effects
"Side effects" can come from both the actions of your drug on its key target and from actions on other targets
43
Can antagonists be competitive and non competitive
Yes, competitive and reversible binding and non competitive is irreversible which will reduce the total amount of receptors available to bind agonist
44
Pharmacokinetics
how the body deals with the drug
45
Important phases of how the drug move in and out of our tissues/bodies
ADME
A= Absorption
D= Distribution
M= Metabolism
E= Excretion
T= Toxicity (sometimes)
46
Absorption
Many factors influence absorption, especially route of administration.
-I.V. route bypasses most barriers to get to plasma
-Oral -> gut-> liver -> plasma -> kidney -> urine
-All drugs must eventually interact with plasma (central compartment)
-Diffusion can always go both ways between compartments
EX = muscle <-> plasma, gut <-> plasma
47
Passive transport Verse Active transport
Passive = no ATP, diffusion
Active = Facilitated diffusion, drug transporters
48
Discuss key characteristics of the drug that affect absorption
lipid solubility
molecular size & weight
pKa
49
Discuss key characteristics of the tissue that affect absorption
membrane permeability
membrane thickness
pH
local blood flow
local surface area/anatomy
transport mechanisms
50
Frick's Law of Diffusion
most drugs move down their concentration gradient (passive diffusion)
51
How do orally administered drugs move through body?
Must pass through the gut and all blood from the gut passes through the portal vein into the liver before general circulation
- This is an issue because the liver has many CYP's
52
Bioavailability
the fraction of drug absorption into the systemic circulation.
AUC (Area under the curve) of plasma concentration verse time for the i.v route compared to that for the test route (oral)
53
Drug pKa
pH at which 50% of the molecules are ionized
54
Acids verse Bases
Acids are increasingly ionized in a basic environment, bases increasingly ionized in an acid environment
55
How does pKa affect drug diffusion
because difference in pH in body fluids an lead to "trapping" of drugs in certain compartments
-this can affect absorption/elimination
-Trapping can help eliminate drugs through the urine
56
how do you trap a weak base
acidify the urine with ammonium chloride
57
how do you trap a weak acid
alkalinize the urine with sodium bicarbonate
58
Distribution
depends on size of the organ, blood flow, solubility, binding
59
Distribution
depends on size of the organ, blood flow, solubility, binding
60
Drugs are distributed in different phases
starting with high flow ares then low flow ares
61
binding to albumin in plasma dramatically affects what
percent of drug available to distribute to tissue
-adding a second albumin-binding drug can change the "bound verse free" percentage of drug 1. This can contribute to drug side effects
62
How is blood - brain barrier an extra challenge for drug distribution
-Tight junctions between capillary endothelial cells verse fenestrated
-maintains homeostasis and restricts access to toxic xenobiotics / metabolites
63
Volume of distribution (Vd)
the volume that relates the amount of drug given to the body to the plasma concentration
Vd = amount of drug in body / plasma drug concentration
*if drug distributes throughout the body well Vd is large, if drug stays in plasma Vd is small
64
What can Vd be used to calculate
therapeutic does by multiplying by plasma concentration (Cp)
65
Metabolism
biotransformation
this is how the body changes the drug in order to eliminate it
66
Phase I of metabolism
typically uses Cytochrome P-450 family members to add or expose a functional group on the drug, making it more polar
67
Phase II of metabolism
conjugates a bulkier functional group onto the drug in order to further increase water solubility and excretion
68
Several drugs and natural products are known to induce or inhibit the expression/activity of Cyp enzymes. How can
this be a problem?
Cyp enzymes are a group of enzymes encoded by P450 genes and are expressed as membrane bound proteins mostly found in the endoplasmic reticulum of the liver.
-If expressed CyP then this could increase the metabolism of drugs so they never reach receptor
-If inhibited CyP then this could decrease the metabolism of drugs
69
Excretion
enterohepatic circulation =
conjugated drugs in the liver can be carried in the bile into the gut for excretion
-most drugs excreted through the urine by action of kidneys
-Quantified using renal clearance value (CL)
*high CL = fast clearance
70
Zero order kinetics
A fixed amount of drug can be handled at one time (alcohol)
71
First order kinetics
constant fraction of the drug is metabolism per unit of time
-more drug = faster metabolism
72
Half life
time to excrete half of the drug
73
Use half-life and kinetics in order to know how to dose patients to achieve steady-state levels of drug.
Typically takes
4-5 half-lives to reach steady-state.
74
Sex
as a classification, generally as male or female, according to the reproductive organs and functions that derive from the chromosomal complement
75
Gender
person's self representation as male or female or how that person is responded to by social institutions on the basis of the individual's gender presentation
76
Describe strategies to address gender differences in PK/PD across in vitro to post - approval stages
1. Report sex/age of cells/subjects in studies
2. Stratify findings by sex and/pr hormone levels
3. Dose by weight
4. Dose by hormone concentrations / weight or body composition
5. Study pharmacogenomics
6. study hormone drug interactions
-include aged and pregnant persons
77
How PK contribute to sex/gender differences
1. Drug absorption is influenced by body composition, including body weight, lean mass, free water, and total body fat
2. Distribution is impacted by organ size, blood flow, and total plasma volume are lower in female bodies which is coupled to increased resting heart rates and longer OT intervals
3. Metabolism/excretion, renal and liver functions is lower in women. Males and females have a different constellation of CYP enzyme
4. poly pharmacy
78
How PK contribute to sex/gender differences
1. Hormone fluctuations over life span (In utero through menopause/age matched males)
2. Exogenous administration of hormones (Birth control, hormone replacement, gender affirming therapies, lifestyle)
3. Formulation responsively, changes in half life
79
The autonomic nervous system (ANS)
provides involuntary, subconscious regulation of all organs and glands, controlling for example the blood pressure, heart and lung function, digestion, body temperature, metabolism, sweating, pupil size and secretions of certain glands
80
What does the ANS consists of
-The sympathetic division (SNS) that is activated during the "fight and flight" response to stress
-The parasympathetic division (PSNS) that promotes conservation and restoration of energy "rest and digest" response
81
Enteric nervous system
works in parallel to the sympathetic and parasympathetic systems to regulate the peristalsis of gut wall and activity of GI tract
82
What does the anatomical organization of the ANS consists of
preganglionic neurons residing in the CNS that extend to the peripheral peripheral autonomic ganglion where they synapse on postganglionic neurons. Postganglionic neurons innervate the target organ
83
What do the neurotransmitters of the ANS include
1) acetylcholine, release from all preganglionic neurons and from parasympathetic postganglionic neurons
2) norepinephrine released from sympathetic postganglionic neurons
3)epinephrine released upon sympathetic activation from the adrenal medulla
84
What do norepinephrine and epinephrine act on what
α and β adrenergic receptors of sympathetic
targets.
85
Acetylcholine acts on nicotinic ACh receptors on
all postganglionic cells and on muscarinic ACh receptors expressed on target organs of the PSNS
86
Blood vessels
receive mostly only sympathetic innervation
-Activation of smooth muscle α1-adrenergic receptors causes vasoconstriction.
- Activation of β2-adrenergic receptor in skeletal muscle and liver vasculatures produces vasodilation
87
Heart
-receives dual sympathetic and parasympathetic innervation with opposing roles.
- Sympathetic stimulation increases the natural pacemaker activity of the heart cells through effects on the ß1 receptors resulting in increased heart rate.
- Parasympathetic stimulation decreases the heart rate through effects on M2 muscarinic receptors
88
Lungs
- Sympathetic activation increases the diameter of bronchioles (bronchodilation), increasing the air flow.
- Parasympathetic activity produces bronchoconstriction
89
Eye
- Activation of the M3 muscarinic receptors causes ciliary muscle contraction to accommodate the lens for near vision. There is no significant sympathetic innervation of the ciliary muscle.
- Sympathetic activation constricts the dilator (radial) pupillae muscle of the iris resulting in pupil dilation (mydriasis).
- Parasympathetic activation constricts the sphincter (circular) pupillae muscle causing the pupil to constrict (miosis)
90
The German-Swiss Renaissance physician, botanist, alchemist and astrologer Paracelsus was famous for which of the following sayings:
"The dose makes the poison."
91
What ligand type does NOT change the energy landscape of the receptor?
Neutral Antagonist
92
What ligand type does NOT change the energy landscape of the receptor?
Neutral Antagonist
93
Your drug is a weak base with a pKa of 7.0. What compartment will cause the highest level of drug trapping?
Stomach, pH 2.0
94
Sex Differences in drug distribution can be influenced by:
a) Organ size, blood flow, and total plasma volume
b) Increased resting heart rates and longer QT intervals in female
c) Gastric motility
d) Transporter expression patterns and levels
95
Which neurotransmitter(s) are released by preganglionic sympathetic neurons?
acetylcholine
96
Epinephrine is used therapeutically in all of the following situations EXCEPT:
a) Severe allergic reactions (Epipen)
b)Bronchial dilator
c) Cardiac stimulant in emergencies
d) Post-operative ileus and bladder retention
) Post-operative ileus and bladder retention
97
Side effects of direct and indirect cholinergic medications include all of the following EXCEPT:
a) Runny nose
b) Salivation
c) Decreased urge to use the bathroom
d) Sweating
Decreased urge to use the bathroom
98
What is the primary vascular effect of treatment with beta 2 adrenergic receptor agonists?
vasodilation resulting in decreased blood pressure
99
A 60 year old man had a MI (heart attack) in the past. His lipids are abnormal: High total and high LDL cholesterol. Which of these drugs would be prescribed?
Atorvastatin
100
Which of the following drug classes are useful in the control of hypertension?
a) Calcium channel blockers
b) Angiotensin receptor blockers (ARBs)
c) Thiazide diuretics
beta
RAAS
vasodilators
101
What is the first substance demonstrated to function as a neurotransmitter
Acetylcholine
102
Can Acetylcholine derivates be non-selective and selective?
Yes, derivates like methacholine, carbachol, bethanechol are non-selective which can be nicotinic and muscarinic ot selective muscarinic receptor agonist that mimic physiological effects of acetylcholine
103
What are plant alkaloids
muscarine and pilocarpine are selective muscarininc acetylcholine receptor agonist
104
What are cholinesterase inhibitors?
neostigmine and physostigmine that block degradation of acetylcholine as the synapse, acting as indirect cholinergic agonists
105
What are direct and indirect cholinergic agonists used to treat
glaucoma, muscle weakness in myasthenia gravis and to stimulate GI and urinary function
106
What is muscarinic cholingeric overdose
it is characterized by SLUDGE or PUDDLES response
-miosis, salvation, lacrimation urination, defecation, GI upset, emesis and can be life threatening (coma)
107
are selective nicotinic agonist limited in therapeutic use?
Yes, use in nicotine addiction
108
What is nicotine overdose with organophosphates
involved in muscle weakness, fatigue, ad at high doses tachycardia, bronchoconstriction and paralysis
109
What are muscarinic acetylcholine antagonist
atropine, scopolamine, ipratropium, which block the parasympathetic effects of acetylcholine
110
What are muscarininc antagonists used to treat
overreactive urinary and GI function, and as bronchodilators for the treatment of asthma ad chronic obstructive pulmonary disease (COPD)
111
What can nicotinic antagonists be used as?
skeletal muscle relaxants during surgeries (intubation) or mechanical ventilation
112
What are side effects of muscarinic antagonists
Dry mouth and skin, mydriasis, constipation, urinary retention, tachycardia and may be severe with high doses producing hallucinations and coma
113
Acetylcholine
Released from all sympathetic and parasympathetic preganglionic cells (nAChR)
From postganglionic cells of the parasympathetic system (mAChR)
From motor neurons (nAChR)
114
Norepinephrine
Released from postganglionic cells of the sympathetic system (α, β AR)
115
Epinephrine
Released from adrenal medulla (α, β AR)
116
Epinephrine
Released from adrenal medulla (α, β AR)
117
Endogenous adrenergic neurotransmitters differ in their release and receptor selectivity
Epinephrine= is released from chromaffin cells of the adrenal medulla into the blood stream and binds to all alpha and beta receptors
Norepinephrine= is released from the posganalionic neurons of the sympathetic nervous system and binds to all alpha and beta1 receptors but NOT b2 receptors
118
alpha 1 receptors
activation produces vasoconstriction leading to increase blood pressure
119
alpha 1 agonist
phenylephrine is used as a nasal decongestant and to improve circulation in hypotensive shock
120
alpha 1 receptor antagonist
prazosin can be used in the management of hypertension
121
alpha 2 receptors
mostly presynpatic, their stimulation inhibits norepinephrine release
122
alpha 2 agonists
clonidine used as antihyertensive drugs
123
beta 1 receptors
activation stimulates the heart
124
beta 1 receptor agonist
dobutamine used to stimulate the heart in cases of cardiogenic shock
125
selective beta 1 antagonists
cardio selective beta blockers metroprolol are used for management of hypertension, angina, cardiac arrhythmias, and other cardiac disorders
126
beta 2 receptors
mediate vasodilation and bronchodilation
127
beta 2 receptor agonists
albuterol are used to dilate bronchial airways in the management of airway diseases (COPD, asthma)
128
indirect sympathomimetics
the main action is by increasing the release of norepinephrine or by blockade of norepinephrine reuptake (NE transport)
129
cocaine
is the only local anesthetic that produces vasoconstriction and can be used locally in some surgical procedures requiring vasoconstriciton and local anesthesia and to control excessive nose bleeds because cocaine is a CNS stimulate it is used to blockade of monoamine transporters and increase and arenergic, dopaminergic an serotonergic neurotransmission
130
Myocardial
Infarction
death of heart muscle die to sudden blockage of blood flow to the area, almost always caused by atherosclerosis buildup allowing for a blood clot to form
131
Stoke
a brain infarction, blockage of blood flow to/in the brain leading to death of brain tissue. Also caused by atherosclerosis, or a clot can also be formed in the heart and move to the brain
132
Stoke
a brain infarction, blockage of blood flow to/in the brain leading to death of brain tissue. Also caused by atherosclerosis, or a clot can also be formed in the heart and move to the brain
133
Risk factors for heart attack or stroke
high LDL, low HDL, cigarette smoking, hypertension, increased age, diabetes, estrogen, physical inactivity
-male gender, obesity, hostile personality, family history
134
vulnerable verse stable plaques features
vulnerable = fibrous cap thickness is small lipid core size is large
stable= fibrous cap thickness is large lipid core size is small
135
what is the leading cause of death in the US
cardiovascular disease
136
what is the leading risk factor of CVD
abnormal cholesterol and lipids in blood
137
statin
the leading drug used to prevent heart attach
-work by blocking HMG-coA reductase in the liver, leads to reduce liver cholesterol synthesis, increased LdL receptors in the liver and cholesterol uptake
138
other CVD therapies
bile acids sequestrants, nicotinic acid, fibric acid derivatives, cholesterol absorption inhibitors, omega 3 fatty acids
139
Why do statins cause a significant reduction in coronary events
increase certain liver enzymes
decrease in cholesterol with stain treatment show largest effect with initial dose then diminish returns
-but they can cause myopathy
-can be combined with other therapies
140
what does combing statins with fibrate therapy do
may increase chance of rhabdomyolysis
141
what do fish oils do
prescription fish oils help lower triglycerides, but they need high dose to have mild effects
142
omega 3 therapy effects
increase in bleeding
purchased from reputable source that uses purification methods
Omega 3 = icosapent ethyl did show reduction in cardiovascular events over time
143
pcsk9 inhibitor
praluent, repatha
work by increasing LDL reuptake receptors on liver cells
-very expensive
144
what do statins and nicotinic acid both increase
HDL to be protective against cardiovascular events
145
If a patient presents at the hospital with acute MI, the initial therapeutic goals are to
improve blood flow
into the heart (thrombolytic agents, antigoagulants, anti-platelet drugs, angioplasty), prevent new clot formation,
decrease work of the heart, correct risk factors later.
146
Anticoagulants
block clotting cascade. Heparin (injectable), warfarin (oral) are classic anticoagulants, but can be too slow to work in the acute setting.
Newer anticoagulants = Dabigatran, etc. Usually used to prevent stroke or
thrombosis in high-risk patients, not in acute MI setting
147
Anti-platelet agents
Classic = aspirin. Blocks platelet activation, therefore reducing clot formation.
Is known to reduce
risk of CVD/death, but can cause some side effects at higher doses.
81mg/day (“baby aspirin”) sufficient to protect very
well.
Recommended for patients with known CVD, adults with diabetes, other cardiovascular risk factors (should check
with physician)
148
To decrease the work of the heart what would you use
use either beta blockers (reduce heart rate and bp), Ace inhibitors/ARBs, or nitrates.
149
ACEi
angiotensin converting enzyme inhibitor
Angiotensin does many things
including increasing blood pressure, so blocking its synthesis (ACEi) or blocking its receptor (ARB) can reduce bp. Side
effects = cough, dizziness, too low BP.
150
ARB
angiotensin-receptor blocker.
Angiotensin does many things
including increasing blood pressure, so blocking its synthesis (ACEi) or blocking its receptor (ARB) can reduce bp. Side
effects = cough, dizziness, too low BP.
151
Beta blockers
decrease heart rate, bp, force of contraction. Can cause tiredness, dizziness, impotence. (which beta
receptor is the primary target here?) B1 because agonist stimulate HR but antagonist decreased HR and B2 relate to lung and bronchodilation
152
Hypertension Risk Factors
-age
-weight
-gender
-race
-diet (high sodium intake)
-alcohol and tobacco use
153
normal blood pressure
less than 120/80 mm Hg
154
what does starting hypertensives following a cardiac event do
reduces future morbidity and mortality
155
what drugs make controlling BP difficult
NSAIDS, normal contraceptives, chemotherapeutic agents (sorafenib) and various herbal compounds (guarana)
156
why are diuretics good at controlling hypertension
because the act to increase urine production and decrease BP by decreasing blood volume (furosemide), also thiazide diuretics (chlorothiazide and hydrocholorothiazide: HCTZ), and K+ sparing diuretics (spironolactone) also called aldosterone antagonists
157
why are RAAS good at controlling hypertension
Renin antiotensin aldosterone system blockers block conversion or angiotensin I into angiotensin II via ACE OR block the angiotension II receptor (ARB). Both reduce BP by relaxing blood vessels across the body
-ACE inhibitors = captopril
-ARB = losartan
158
why are Beta Blockers good at controlling hypertension
because they inhibit beta-1, beta-2 and occasionally alpha-1 activity to reduce cardiac contractility, heart rate, and cardiac conduction to lower overall BP
-Nonselective [propranolol], cardio-selective via beta-1 [metoprolol], and w/alpha-1 blocking activity [carvedilol])
-Normally used as first line therapy for angina and heart failure, second to third line for hypertension control
159
why are Calcium channel blockers good at controlling hypertension
because they dilate blood vessels and slow heart rate to reduce BP.
-Dihydropyridine dilates w/o
conduction system effect & Non-dihydropyridine w/conduction system effect.
- (DHP [nifedipine], Non-DHP [verapamil]
160
why are vasodilators good at controlling hypertension
because they act directly on blood vessels to rapidly dilates, useful in cardiac and ischemic emergencies
-Nitric Oxides and Nitrates
161
side effects of antihypertensives
-dry cough w/ACE inhibitors
-gout,hypokalemia, glucose intolerance w/thiazides
-excessive hypotension and angioedema w/ACE/ARB
-asthma aggravation w/beta blockers
162
current principles about treating hypertension
Rule out extraneous causes before starting treatment
(illicit drugs, OTC’s)
* Combining diet and exercise with pharmacotherapy
is critical for successful management
* Diabetes, CHF, CAD, PAD, sleep apnea, obesity
are all commonly associated comorbidities
* Typical regimens for control
are ACE/ARB+diuretic or CCB+diuretic
163
over the counter drug
describes drugs that can be purchased without a prescription from a doctor
164
how do OTC drugs compare to prescription drugs
tend to have less side effects but are not harmless. Prescription drugs could
require monitoring because they are habit-forming, require frequent check-ins with a doctor, or are new to the
market. Over time, some prescription medications may be deemed safe and moved to the OTC category
165
The most common ingredients in OTC drugs are
acetaminophen (ex: Tylenol) and ibuprofen (Advil). Most cold and flu
medications contain acetaminophen + other active ingredients
166
Analgesics
pain medications. Acetaminophen, NSAIDS (aspirin, ibuprofen) = Cox2 inhibitors
167
Cox2
enzyme which causes the release of prostaglandins, specifically PGE2, which along with other inflammatory agents
can increase the sensitivity of nociceptors (pain receptors) in the spine, causing hyperalgesia and allodynia. Cox1 and
Cox2 are also found on inflammatory cells, so their blockade can reduce inflammation. Blocking Cox enzymes also
inhibits fever, by blocking the effects of prostaglandins on receptors on the thermosensitive neuron in the
hypothalamus.
168
Acetaminophen
commonly used OTC, but can be accidentally overdosed and cause liver toxicity
169
Aspirin
acetylsalicylic acid. Blocks pain, fever, but need higher doses to fight inflammation. Does block platelet
aggregation in small doses. Problem: causes increased HCl in stomach, can lead to ulcer. Can cause Reye’s syndrome in
kids
170
Ibuprofen
often preferred due to less GI side effects. Discussed some newer alternative compounds with longer half-lives
171
comparing the 3 main analgesics
Tylenol (Acetaminophen) antidote for OD cysteine
Aspirin (Salicylate) no children antiplatelet
Mortrin (Ibuprofen)
pain relievers reversible Cox inhibitor
172
OTC drugs for allergies are anti-histamines
H1 receptor antagonists. Histamines produced in large quantities by mast
cell
173
Stimulation of H1 receptors by histamines released by
inflammatory cells can cause an allergic reaction.
Ex: pruritus, vasodilation/permeability, flushing, headache, bronchoconstriction, and pain. Anti-histamines block
these effects. Side effects include sedation, anti-cholinergic activities
174
OTC cough suppressant
Anti-Tussives). Can include expectorants (ex: Guaifenesin) or cough suppressants
(Dextromethorphan
175
OTC nasal decongestant
alpha-adrenergic agonists. Stimulates contraction of blood vessels in nasal passages, allowing
for better drainage (and breathing). Side effects include damage to the mucosa and desensitization
176
Cyclooxygenase
prostaglandin
synthesis
Cyclooxygenase-2 products
Modulate pain perception
Promote fever through receptors in hypothalamus
Modulate inflammatory response
177
Benadryl (Diphenhydramine)
Antihistamines
H1 receptor “antagonists” reduce constitutive activity of the receptor
and compete for histamine.
178
PGE2
PGE2 can cross the blood-brain barrier and acts on EP3/EP1 receptors in
the thermosensitive neuron.
179
Antipyretic
fever reducers
180
OTC drugs can be abuse
such as Dextromethorphan, ephedrine, pseudoephedrine (now replaced by phenylephrine)
181
Physical symptoms of depression
anhedonia, loss of energy, social withdrawal, psychomotor retardation or agitation, somatic complaints, appetite/weight loss, decreased hygiene,
crying spells
182
Cognitive symptoms of depression
Decreased ability to concentration, indecisiveness
183
Emotional symptoms of depression
Dysphoric mood, sad thoughts or attempts at suicide, hopelessness, helplessness, worthlessness, guilt, shame
184
what can depression be caused by
genetics, brain/neuron damage, or HPA overactivation and CRF hypersecretion
185
what do PET scans show in depression
decreased brain activity in patients with depression
186
bipolar disorder
marked by unusual shifts in mood with episodes of mania and depression
187
major depressive disorder
symptoms of depression most of the day, nearly every day for at least 2 weeks that interfere with your ability to work sleep, study, eat, and enjoy life. An episode can occur only once in a persons lifetime, but more often a person has several episodes
188
persistent depressive disorder (dysthymia)
having symptoms of depression that last for at least 2 years. A person diagnosed with this for of depression may have episodes of major depression along with periods of less severe symptoms
189
biogenic amine hypothesis
depression caused by deficiency in catecholamines (norepinephrine, NE) and/or indoleamines (serotonin; 5HT)
190
small study on doctors were trying to treat hypertensive patients
The patients were tested for depression and treated for hypertension them with Reserpine (VMAT inhibitor). This prevents release of neurotransmitters (it targeted VMAT) leading patients to develop depression
191
Types of Antidepressants
1. SSRI’s: block 5-HT reuptake.
2. SNRI’s: block 5-HT & NE reuptake, without effects on other receptors.
3. Tricyclics: block the reuptake of both NE and 5-HT, with effects on a number of other receptors.
4. MAOI’s: prevent metabolism of the neurotransmitters (elevate synaptic levels).
5. Atypical: have SSRI effects, 5-HT2 antagonism, and inhibition of norepinephrine reuptake
192
MOIs
target MAO to allow more serotonin and norepinephrine to be taken up in vesicles and released in synaptic cleft
-MAOIs are not used much anymore due to drug-drug and drug-food interactions and risk of hypertension crisis (stroke)
-*Wine and Cheese*: Tyramine does not cross BBB. Unmetabolized tyramine can function as a “false” neurotransmitter, potentiating
catecholamine (NE/DA/5HT) release from terminals, causing vasoconstriction.
-Phenelzine and Tranylcypromine are both still used
193
TCAs
have affinity for both SERT and NET. Relative affinity is not equal (e.g., desipramine has higher affinity for NET vs SERT)
-TCAs are still used (Amitriptyline) especially in developing countries, but have anticholinergic effects (dry mouth and eyes, urinary hesitancy or retention, and constipation)
-used for neuropathic pain ( e.g., migraine) and insomnia
194
SSRI
block SERT and end up with more serotonin able to bind to 5HT2A
-Excessive levels with serotonin can lead to side effects (ex: lots of binding = anxiety)
-Citalopram, Fluoxetine, Sertraline
195
SNIR
block NETs (similar mechanism to SSRIs)
-Side effects include increase blood pressure and heart rate, orthostatic hypotension (stand up and get lightheaded).
-SNRIs are better for treating pain associated with neuropathy and fibromyalgia compared to SSRIs
-Venlafaxine, Duloxetine
196
Mirtazapine
blocks α2AR which then allows for release of neurotransmitters, and also blocks 5HT2A receptors allowing for more serotonin in synaptic cleft
197
Bupropion
blocks NET and DAT
198
Trazodone & Nefazodone:
blocks SERT, NET, 5HT2A receptors, and beta alpha 1 receptors
199
Therapeutic effect is usually not acutely evident but
chronically present after the patient has been taking the medication for 4 weeks
200
Mania
too much biogenic amine neurotransmission.
- Reduced by Lithium (by reducing IP-3 production) but the issue is that Li is solely eliminated by the kidney and therefore has a very small therapeutic
window
201
seizures
Clinical manifestation of abnormal
and excessive excitation and synchronization of a population of neuron
202
epilepsy
Disease characterized by spontaneous recurrent seizures
203
Generation of action potential
actions potentials are triggered with an influx of sodium through voltage gated sodium channels which lead to an upstroke followed by a downstroke where k channels open and then it gets rest
*potassium channels open and close but sodium channels open inactive and then need to be reactive in order to open again
204
epileptogensis
sequence of events that convert a normal neuronal network into an epileptic network
205
Describe in detail the 4 ways that AEDs can decrease neuronal discharge
1.Decrease Na+ channel depolarization (carbamazepine, lamotrigine,
oxcarbazepine, phenytoin, topiramate, valproate)
2.Decrease glutamate transmission
*Block presynaptic HVA Ca2+ (topiramate, lamotrigine)
*Block presynaptic α2δ1 (gabapentin, pregabalin)
*Block SV2A (levetiracetam)
3. Decrease Ca2+ permeability
*Block postsynaptic (T-type) Ca2+ (valproate, zonisamide,
ethosuximide)
4. Enhance GABA inhibition
*Facilitating Cl- conductance: barbiturates, benzodiazepines
*Facilitating/stabiling K+ conductance: retigabine
*Blocking GABA reuptake: tiagabine
*Blocking GABA transaminase: Vigabatrin
206
Vigabatrin
Blocking GABA transaminase:
207
tiagabine
Blocking GABA reuptake:
208
retigabine
Facilitating/stabiling K+ conductance:
209
barbiturates, benzodiazepines
Facilitating Cl- conductance
210
topiramate, lamotrigine
Decrease glutamate transmission
*Block presynaptic HVA Ca2+
211
levetiracetam
Decrease glutamate transmission
Block SV2A
212
gabapentin, pregabalin
Decrease glutamate transmission
Block presynaptic α2δ1
213
Valproate
give to patient three abscess motor but do not want to give to a female who is pregnant because can lead to spina bifida
214
Phenytoin
Dilantin
Zero-Order Kinetics
side effects of toxicity
Gingival hyperplasia (overgrowth of gums)
Hirsutism(excess hair)
Nystagmus (eyes moving)
215
motor drugs do what to action potential
SLOWS the Inactivation....NOT the Activation
216
carbamazepine
Induces microsomal enzymes, =
speeding its own metabolism.
Toxicity: toxic
epidermal necrolysis (STOP
DRUG!), cardiac arrhythmias if see this give Lamotrigine could see Stevens–Johnson
syndrome (SJS) /
Toxic epidermal
necrolysis:
217
carbamazepine, lamotrigine,
oxcarbazepine, phenytoin, topiramate, valproate
Motor problem seizures
Decrease Na+ channel depolarization
218
Describe mechanism of action & toxicity associated with drug treatments for patient 1
lipsmacking
focale (because still aware)
motor (because moving against will)
carbamazepine
phenytoin
lamotrigine
valproate
benzodiazepines
NOT ethosuximide because thats for absence seizures
219
Describe mechanism of action & toxicity associated with drug treatments for patient 2
absence without motor symptoms
ethosuximide
lamotrigine
220
Describe mechanism of action & toxicity associated with drug treatments for patient 3
absence with motor symptoms (tonic clonic)
ethosuximide
lamotrigine
valproate
221
Describe mechanism of action & toxicity associated with drug treatments for patient 4
generalized absence tonic clonic
phenytoin
valproate
ethosuximide
222
difference between benzo and barbs
benzos: increase the frequency
barbs: the make it so the GABA receptors cannot close as quickly -do not change the frequency
223
Describe mechanism of action & toxicity associated with drug treatments for patient 5
tonic clonic seizure over 5 minutes = status epilepticus
benzodiazepines
Klonopin
Valium
Diazepam
224
Describe the non-linear relationship of dose and plasma concentration of phenytoin
zero order kinetics
so everyone has a different therapeutic range
225
Describe the alternative treatments for patients who are unresponsive to treatment or require adjunct therapy
patient 1 & 4 = Zonisamide, Levetiracetam, Topiramate
patient 2 & 3 = Levetiracetam
226
There are many forms of viruses, in 2 main classes
DNA viruses and RNA viruses (retroviruses carry RNA but must convert the genome to DNA before replication).
227
Stages of viral replication
Cell entry (attachment, penetration), Uncoating, transcription of viral genome, translation of viral proteins, post-translational modifications (cleavage), assembly of new virion components, release (budding)
228
First antiviral drug was Acyclovir
discovered by Gertrude Elion and George Hitchings in the 1960s. Used for treatment of Viral herpes. Is a nucleoside analog. Acyclovir is unique in that it must be metabolized by herpes thymidine kinase in order to be used
229
Anti-influenza virus
drugs include Arantadine and Rimantadine, which inhibit viral uncoating. Or Tamiflu (Oseltamivir) or Relenza (Zanamivir) which inhibit the neuraminidase enzyme of influenza A or B viruses, causing viral aggregation at the cell surface so the new particles can’t be released.
230
COVID-19 vs the Flu
both viruses spread similarly, have similar symptoms, and can be mild or severe. Differences: sometimes delayed onset of symptoms for COVID-19, which is often more severe/deadly than the flu
231
Several treatments are currently being investigated/used in special cases to treat patients with COVID-19
At home, at-risk patients may be prescribed Lagevrio (molnupiravir – nucleoside analogue, can cause mutations
in viral DNA), or Paxlovid (combination of 2 protease inhibitors, nirmatrelvir and ritonavir)
232
Hospitalized patients may also be prescribed:
1) The monoclonal antibody Bamlanivimab
2) The viral RNA-polymerase inhibitor Remdesivir
3) Dexamethasone: steroid that helps reduce systemic inflammation, found to reduce mortality for some patients
233
Heptatitis
Caused by viruses spread by fecal matter (HPV A), or bodily fluids (HPV B, HPV C). Can cause liver damage, weaken the immune system, cause liver cancer, failure, death. Often no early symptoms
234
Interferons
are naturally occurring, immune stimulatory proteins that, when used as drugs, are purified and injected
into the patient to stimulate specific immune responses. Work as anti-virals in many different ways.
Downsides:
expensive, nasty side effects, can only be used in a relatively healthy subset of patients, and don’t always work.
235
Raltegravir
binds to HIV DNA Integrase and blocks its ability to insert the HIV genome into the host genome.
236
HIV protease inhibitors
(peptidomimetic) can block the cleavage of precursor HIV proteins into their mature, functional
forms.
* Prophylactic (PrEP) drugs are now available for individuals who may be at high risk of HIV exposure that can reduce the risk
of infection by 90%, but must be taken daily. Truvada can be used for PrEP.
237
Reverse transcriptase inhibitors
can either mimic nucleotides/nucleosides and block further DNA replication, or bind
elsewhere on the reverse transcriptase enzyme and block its activity
238
HIV binds to CD4+ immune cells by binding to the CD4 receptor
ith help from the CXCR4 and CCR5
co-receptors. HIV is a retrovirus, which is an RNA virus that needs to reverse-transcribe its genome to DNA, then
it integrates its genome into the host DNA before using host machinery to replicate
239
Discussed the need for constant turnover of cells in the body
thus constant DNA replication and opportunities for
for mutations to occur that aren’t repaired (in addition to environmental mutagens). In normal conditions, cell
proliferation, differentiation and death are well-orchestrated to keep our bodies at homeostasis
240
hallmarks of cancer cells
involves loss of normal control mechanisms governing cell survival,
proliferation and differentiation, capable of metastasis, can undergo clonal expansion, often contain mutations
and chromosomal abnormalities.
241
intracellular signaling networks
are keys to allowing for operations of the cancer cell. They rely on
dysregulation of normal signaling to survive
242
Oncogene
a gene having the potential to cause cancer. Often mutated or expressed at high levels in cancer.
- Growth factors, growth factor receptors, signaling molecules, anti-apoptotic genes, transcription factors for cell
proliferation (see examples on slide 7). Can be stimulated by translocation/transposition, gene amplification, or point
mutations (in promoter or within the gene)
243
Tumor Suppressor Gene
Protect cells against becoming cancerous. Often they are inhibitors of cell growth that become
mutated or lost in cancer. Examples: p53, Rb, PTEN
244
Log-kill hypothesis
If cancer cells are undergoing logarithmic growth, it is much more effective to treat
them early when there are orders of magnitude fewer cells to kill. But this requires early diagnosis and
treatment. Also, chemotherapeutic drugs only kill a certain fraction of tumor cells each cycle, so multiple rounds of
chemotherapy are required to achieve significant reduction in tumor burden
245
Antimetabolites
Inhibit DNA or RNA synthesis. Purine analogs, pyrimidine analogs, folate analogs
246
Alkylating agents
Chemically modify DNA, RNA or proteins by adding an alkyl group
247
Natural products
There are many, but we discussed vinca alkyloids (disrupt microtubule formation), taxanes (enhance
tubulin polymerization and don’t allow them to resolve for the next phase of the cell cycle), Etoposide ( inhibits
DNA topoisomerase II), camptothecins (inhibits DNA topoisomerase I), anthrocyclines (inhibits DNA topoisomerase
II, intercalates DNA, makes free radicals), mitomycin (cross links DNA), bleomycin (binds DNA, causes strand breaks).
248
Hormones and analogues
for hormone-dependent cancers. Can induce apoptosis
249
tyrosine kinase inhibitors
can work through binding to the ATP binding site (e.g.: Lapatinib), but this can also have
off-target effects.
There are many of these inhibitors being used, with varying effects. Monoclonal antibodies are also available
to target tyrosine kinases. They can block the ligand for the receptor, bind to the receptor itself, or prevent
dimerization of the receptor – each of which inhibits downstream signaling
250
Neurominidase
inhibits influenza an enzyme on the surface of viruses
enabling the virus to be released from the host cells.
251
Herceptin
(Trastuzumab) is an antibody against the HER2 receptor which can be overexpressed in breast cancer
252
Combination therapy
Helpful to treat the cancer while reducing the
risk of developing resistance
The combination called R-CHOP is often used for Non-Hodgkins Lymphoma.
R = Rituximab (antibody against cancer cells)
C = cyclophosphamide (alkylating agent which binds DNA)
H = Doxorubicin Hydrochloride (an anthracycline, blocks topoisomerase II)
O = Oncovin (Vincristine Sulfate, a vinca alkyloid)
P = Prednisone (corticosteroid)
253
Three main types of immune stimulatory therapies
1) Blocking the CTLA-4
immune checkpoint, 2) Blocking the PD-1/PD-L1 immune checkpoint, 3) T-cell transfer
254
Pyrimidine analogue
Purine or Pyrimidine Analogs
Foscarnet=pyrophosphate analog
anti herpes drugs that target virus
255
General Structure of Viruses
1) Core: single or double stranded DNA or RNA
2) Capsid: protein shell
3) Envelope: phospholipids and proteins
256
Integrase
Raltegravir binds to hIV integrase and prevents DNA strand transfer
257
Herpes Simplex virus
DNA virus
258
Acyclovir (zovirax)
first antiviral drug
for viral herpes
analog of nucleoside
adds phosphate groups and gets stuck
259
Viral protease
inhibitor peptidomimetic
260
Hepatitis B
usually no symptoms pases vua blood or body fluids vaccine preventable
261
Mechanisms of resistance
1) Inactivation by b-lactamases (over hundreds)- inactivate beta-lactam antibiotics by hydrolyzing the peptide
bond of the characteristic four-membered beta-lactam ring rendering the antibiotic ineffective
2) Modification of Penicillin-bind proteins (PBPs, transpeptidase)- mutation of PBPs
3) Impaired penetration of drug to target PBPs- can’t get into cell
4) efflux- get kicked out
262
Gyrase
DNA gyrase
quinolones
263
50S ribosomal inhibitors
targeted by macrolides, clindamycin, linezolid
264
30S ribosomal inhibitors
targeted by tetracyclines and aminoglycosides
265
Macrolide
Erythromycin, Clarithromycin, Azithromycin
Binding to 50S ribosomal RNA near the peptidyltransferase center
266
Beta-lactam antibiotic
mimic D-Ala-D-Ala and inhibit
activity of the transpeptidase that uses them.
mimic the bacteria cell wall and then puts a cephalosporins to stop bacteria from making cell wall
Resistance
1) Inactivation by b-lactamases (over hundreds)
2) Modification of Penicillin-bind proteins (PBPs, transpeptidase)
3) Impaired penetration of drug to target PBPs
4) efflux kicking drug back out
267
Louis Pasteur
diseases were caused by germs
268
gram positive
bacteria with big cell walls
269
gram negative
small cell wall
270
Streptomycin
its an aminoglycoside and best for gram neg
makes RNA not be able to read correctly
binds to 30s
271
gabapentin, pregabalin
Block presynaptic α2δ1
272
gabapentin, pregabalin
Block presynaptic α2δ1
